Clinical Trial Update: Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Exparel and Marcaine for pain management in thoracoscopic lobectomy; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Exparel (liposomal bupivacaine)
• Marcaine (bupivacaine)

Snippet

Sponsor: Southern Illinois University | Conditions: Non Small Cell Lung Cancer, Lung Cancer Stage 1 | Phase 3 | Status: COMPLETED | Results posted: 2023-01-12